Glycovaxyn Is A Private Swiss Biotechnology Company Developing A Broad Portfolio Of Novel Bioconjugate Vaccines To Prevent And Treat Commonsevere Bacterial Infections Using Its Proprietary Glycoprotein Technology
No conferences found for this company.
| Company Name | Glycovaxyn Ag |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.